| Mario J Gaspar De Alba, MD | |
|
630 S Rancho Dr Ste A, Las Vegas, NV 89106-4849 | |
| (702) 998-9505 | |
| (702) 527-7939 |
| Full Name | Mario J Gaspar De Alba |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Developmental - Behavioral Pediatrics |
| Location | 630 S Rancho Dr Ste A, Las Vegas, Nevada |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275546590 | NPI | - | NPPES |
| 1275546590 | Medicaid | NV | |
| 178999201 | Medicaid | TX | |
| GW226Z | Other | NV | MEDICARE |
| 8H0437 | Other | TX | BC/BS OF TEXAS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0006X | Pediatrics - Developmental - Behavioral Pediatrics | M3232 (Texas) | Secondary |
| 2080P0006X | Pediatrics - Developmental - Behavioral Pediatrics | 14554 (Nevada) | Primary |
| Entity Name | Unlv Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407397235 PECOS PAC ID: 4183991458 Enrollment ID: O20170517002454 |
News Archive
Boehringer Ingelheim today announced overall survival (OS) results from the LUX-Lung 8 trial (NCT01523587) that directly compared the efficacy and safety of two EGFR-directed treatments, afatinib and erlotinib, in patients with advanced squamous cell carcinoma (SCC) of the lung, progressing after treatment with first-line chemotherapy. Treatment with afatinib significantly reduced the risk of death by 19%, extending the survival of patients to a median of 7.9 months compared to 6.8 months on erlotinib.
Healthcare Information and Management Systems Society (HIMSS) announced that Nemours, a premiere healthcare system for children operating in Delaware, Pennsylvania, New Jersey and Florida, is a 2010 recipient of its prestigious HIMSS Davies Organizational Award of Excellence.
The National Institutes of Health has launched a centralized, secure enclave to store and study vast amounts of medical record data from people diagnosed with coronavirus disease across the country.
Unigene Laboratories, Inc. today announced that the Company terminated its amended and restated exclusive worldwide license agreement and related development services and clinical supply agreement with GlaxoSmithKline (GSK) pertaining to an oral formulation of a recombinantly produced parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women.
Now on Capsules, Christian Torres writes about a new federal coordinated care initiative: If the Department of Health and Human Services has its way, hundreds of physician practices will follow the money and take up a coordinated model of health care.
› Verified 6 days ago
| Entity Name | Capability Health & Human Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306983044 PECOS PAC ID: 9739515511 Enrollment ID: O20200214002171 |
News Archive
Boehringer Ingelheim today announced overall survival (OS) results from the LUX-Lung 8 trial (NCT01523587) that directly compared the efficacy and safety of two EGFR-directed treatments, afatinib and erlotinib, in patients with advanced squamous cell carcinoma (SCC) of the lung, progressing after treatment with first-line chemotherapy. Treatment with afatinib significantly reduced the risk of death by 19%, extending the survival of patients to a median of 7.9 months compared to 6.8 months on erlotinib.
Healthcare Information and Management Systems Society (HIMSS) announced that Nemours, a premiere healthcare system for children operating in Delaware, Pennsylvania, New Jersey and Florida, is a 2010 recipient of its prestigious HIMSS Davies Organizational Award of Excellence.
The National Institutes of Health has launched a centralized, secure enclave to store and study vast amounts of medical record data from people diagnosed with coronavirus disease across the country.
Unigene Laboratories, Inc. today announced that the Company terminated its amended and restated exclusive worldwide license agreement and related development services and clinical supply agreement with GlaxoSmithKline (GSK) pertaining to an oral formulation of a recombinantly produced parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women.
Now on Capsules, Christian Torres writes about a new federal coordinated care initiative: If the Department of Health and Human Services has its way, hundreds of physician practices will follow the money and take up a coordinated model of health care.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mario J Gaspar De Alba, MD 3016 W Charleston Blvd Ste 100, Las Vegas, NV 89102-1973 Ph: () - | Mario J Gaspar De Alba, MD 630 S Rancho Dr Ste A, Las Vegas, NV 89106-4849 Ph: (702) 998-9505 |
News Archive
Boehringer Ingelheim today announced overall survival (OS) results from the LUX-Lung 8 trial (NCT01523587) that directly compared the efficacy and safety of two EGFR-directed treatments, afatinib and erlotinib, in patients with advanced squamous cell carcinoma (SCC) of the lung, progressing after treatment with first-line chemotherapy. Treatment with afatinib significantly reduced the risk of death by 19%, extending the survival of patients to a median of 7.9 months compared to 6.8 months on erlotinib.
Healthcare Information and Management Systems Society (HIMSS) announced that Nemours, a premiere healthcare system for children operating in Delaware, Pennsylvania, New Jersey and Florida, is a 2010 recipient of its prestigious HIMSS Davies Organizational Award of Excellence.
The National Institutes of Health has launched a centralized, secure enclave to store and study vast amounts of medical record data from people diagnosed with coronavirus disease across the country.
Unigene Laboratories, Inc. today announced that the Company terminated its amended and restated exclusive worldwide license agreement and related development services and clinical supply agreement with GlaxoSmithKline (GSK) pertaining to an oral formulation of a recombinantly produced parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women.
Now on Capsules, Christian Torres writes about a new federal coordinated care initiative: If the Department of Health and Human Services has its way, hundreds of physician practices will follow the money and take up a coordinated model of health care.
› Verified 6 days ago
Randi E Lampert, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2050 Mariner Dr, Suite #150, Las Vegas, NV 89128 Phone: 702-228-9066 | |
Sora Song, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3201 S Maryland Pkwy Ste 608, Las Vegas, NV 89109 Phone: 702-457-5437 Fax: 702-464-5801 | |
Dr. Noah Benjamin Kohn, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1800 W. Charleston Blvd., Las Vegas, NV 89102 Phone: 702-383-2000 Fax: 888-456-2467 | |
David Blank, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 10105 Banburry Cross Dr, Suite 370, Las Vegas, NV 89144 Phone: 702-260-4525 Fax: 702-869-0133 | |
Vicki Hom, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4570 S. Eastern Ave, Suite #21, Las Vegas, NV 89119 Phone: 702-733-6033 Fax: 702-733-6033 | |
Ms. Elsa H Von Schulenburg, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4800 Alpine Pl, Suite 10, Las Vegas, NV 89107 Phone: 702-851-3572 Fax: 702-851-3574 | |
Ruben J Acherman, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 3131 La Canada St Ste 230, Las Vegas, NV 89169 Phone: 702-732-1290 Fax: 702-732-1385 |